tocophersolan has been researched along with Acute Liver Injury, Drug-Induced in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Lin, X; Wang, H; Wu, Y | 1 |
Adu-Frimpong, M; Deng, W; Li, W; Li, Y; Ma, P; Sun, C; Xu, X; Yu, J; Zhang, H; Zhu, Y | 1 |
2 other study(ies) available for tocophersolan and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
Crizotinib loaded polydopamine-polylactide-TPGS nanoparticles in targeted therapy for non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Chemical and Drug Induced Liver Injury; Crizotinib; Humans; Lung Neoplasms; Nanoparticles | 2022 |
Development of TPGS/F127/F68 mixed polymeric micelles: Enhanced oral bioavailability and hepatoprotection of syringic acid against carbon tetrachloride-induced hepatotoxicity.
Topics: Administration, Oral; Animals; Biological Availability; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Drug Carriers; Drug Delivery Systems; Gallic Acid; Humans; Liver; Male; Mice; Mice, Inbred ICR; Micelles; Nanoparticles; Oxidative Stress; Polyethylene Glycols; Polyethylenes; Polypropylenes; Propylene Glycols; Rats; Rats, Sprague-Dawley; Vitamin E | 2020 |